FXR has been extensively studied in liver disease, such as innate hepatic inflammation, cholestatic liver disease and non-alcoholic fatty liver disease (NASH) [17]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.